Skip to main content
. 2011 Jul;72(1):51–62. doi: 10.1111/j.1365-2125.2011.03940.x

Table 2.

Parameter values estimated by the final pharmacokinetic model

Parameter Population mean %RSE* 95% confidence interval*
Typical apparent clearance, fast eliminators (CLfast/F, l h−1) 21.6 36.8 18.9, 28.2
Typical apparent clearance, slow eliminators (CLslow/F, l h−1) 9.70 3.05 9.61, 10.7
Typical apparent central volume of distribution (Vc/F, l) 57.7 2.81 56.3, 62.9
Typical apparent peripheral volume of distribution (Vp/F, l) 1730 14.7 1313, 2514
Typical apparent intercompartmental clearance (Q/F, l h−1) 3.34 8.52 2.43, 3.38
Typical absorption rate constant (ka, h−1) 1.85 4.01 1.72, 2.06
Typical absorption lag time (tlag, h) 0.180 7.63 0.166, 0.226
Proportion of fast eliminators in population (Pfast) 0.132 23.2 0.0685, 0.184
Linear effect of positive HIV status on CL/FCL,HIV) −0.174 22.2 −0.266, −0.0990
Linear effect of being female on Vc/FVc,gender,F) −0.103 25.7 −0.205, −0.0861
Interindividual variability (%CV)
Apparent clearance (ωCL2) 18.4 13.6 13.6, 19.3
Apparent central volume of distribution (ωVc2) 16.5 12.6 12.4, 16.8
Apparent intercompartmental clearance (ωQ2) 93.1 25.4 92.1, 132
Relative bioavailability (ωF2) 26.2 9.77 25.2, 29.9
Absorption lag time (ωtlag2) 88.4 9.57 86.6, 102
Interoccasional variability (%CV)
Absorption rate constant (κka2) 90.1 5.92 80.5, 92.0
Relative bioavailability (κF2) 8.4 33.0 8.77, 14.4
Residual variability (standard deviation)
Additive variability for DPM (σ, log scale, mg l−1) 0.205 2.74 0.187–0.229
*

Generated by nonparametric bootstrap, n = 1000. RSE = relative standard error. Typical value of CL/F = CL · (body weight/70)0.75· (1–0.174 · HIV), where CL = 21.6 or 9.70 for fast and slow eliminators, respectively, and HIV = 0 or 1 for negative and positive status, respectively; typical value of Vc/F = 57.7 · (body weight/70) · (1–0.103 · SEX), where SEX is 0 for males and 1 for females; typical value of Vp/F = 1730 · (body weight/70); typical value of Q/F = 3.34 · (body weight/70)0.75.